Search - tctmd.com

Displaying 321 - 340 of 472

Sort: Relevancy | Date

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

More Liberal Definition of Type 2 MI May Misclassify Some Patients

News Daily News

More Liberal Definition of Type 2 MI May Misclassify Some Patients

September 20, 2017

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

September 15, 2017

Acute MI Mortality Has Dropped to Very Low Levels in France

News Conference News ESC 2017

Acute MI Mortality Has Dropped to Very Low Levels in France

September 08, 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

News Conference News ESC 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Michael O'Riordan

August 28, 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

News Conference News ESC 2017

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

Michael O'Riordan

August 26, 2017

Evolocumab Not Cost-Effective at Current List Price

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

Calcium Score Better Than Age for Discriminating Coronary Risk in Older Adults

News Daily News

Calcium Score Better Than Age for Discriminating Coronary Risk in Older Adults

July 27, 2017

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

News Daily News

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

Michael O'Riordan

July 25, 2017

CV Risk Higher With Modestly Elevated Troponin Levels, but Clinical Relevance Remains Unclear

News Daily News

CV Risk Higher With Modestly Elevated Troponin Levels, but Clinical Relevance Remains Unclear

July 24, 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

News Daily News

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

Michael O'Riordan

May 30, 2017

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

News Daily News

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

May 15, 2017

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

News Daily News

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Michael O'Riordan

May 12, 2017

Who Should Get a Statin? Guidelines Don’t Match Up

News Daily News

Who Should Get a Statin? Guidelines Don’t Match Up

Michael O'Riordan

April 20, 2017

One in Five Acute MI Patients Drop Statins Within 2 Years

News Daily News

One in Five Acute MI Patients Drop Statins Within 2 Years

Michael O'Riordan

April 20, 2017

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

News Daily News

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

April 03, 2017

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

News Conference News ACC 2017

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

Michael O'Riordan

March 21, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.